CAS Number: 84696-11-7
Plant that is widely used even during pregnancy and breastfeeding. Because a lack of toxicity with an appropriate dose and moderate consumption it should be compatible with breastfeeding. The roots and aerial summits are used. It contains polysaccharides, essential oil, flavonoids, pyrrolizidine alkaloids among others. Unproven effects: immune stimulant, wound healing, anti-inflammatory. Indications are: common cold, bronchitis, skin lesions.Roots and aerial summits are used. It contains polysaccharides, essential oil, flavonoids, pyrrolizidine alkaloids ... Unproven effects: immune stimulant, wound healing, anti-inflammatory. Indications according to Commission E of German Ministry of Health: common cold, bronchitis, skin lesions. Contrary to the European Scientific Cooperative on Phytotherapy (ESCOP), the European Medication Agency does not recommend usage in younger than 12 years (allergy risk). Avoid using for longer than 8 weeks (risk for leukopenia)
CAS Number: 68990-15-8
The seeds of this leguminous plant are used. Content: carbohydrates, proteins, saponins, vitamins, minerals . Assigned properties: appetite stimulant, lowering of lipemia and glycemic (Gong 2016).Indications according to Commission E of the German Ministry of Health: Anorexia, Atopic Dermatitis. Widely used as a galactogogue in many cultures around the world (Ayers 2000, Winterfeld 2012, Sim 2013, The Royal Women's .. 2013, Bazzano 2016). Case-control studies looking for evidence on the increment of milk production associated to the use of fenugreek are few (Turkyılmaz 2011, Ghasemi 2015), along with a variety of methodological deficiencies. Other studies have failed to find such an effect with the use of fenugreek (Damanik 2006). Studies with an appropriate design are needed to provide high quality evidence to make clinical recommendations on its use (Forinash 2012, Zapantis 2012, Committee LM AEP 2012, Mortel 2013, Bazzano 2016) A higher antioxidant effect in the breastmilk of women who have consumed mixed infusions containing this or other herbs has not been shown (Kavurt 2013). Given the wide spread use and lack of toxicity of this herb, a moderate consumption would be compatible with breastfeeding, yet high doses may produce hypoglycemia (EMA 2011, Gong 2016) and, because of the odor appearing in the urine of the infant, a lab test may be required to make a differential diagnosis with maple syrup disease of the newborn (Sewell 1999, Korman 2001). Avoid the use of a galactogogue without a sanitary control. Best galactagogue results are achieved through on-demand breastfeeding along with an adequate technique in a mother who is able to maintain self-confidence (ABM 2011, Mannion 2012). Precautions when taking plant preparations: 1. Ensure that they are from a reliable source: poisoning has occurred due to confusing one plant with another with toxic properties, as well as poisoning from heavy metals extracted from the ground and food poisoning due to contamination with bacteria or fungi. 2. Do not take in large amounts; follow recommendations from professional experts in phytotherapy. "Natural" products are not always good in any quantity: plants contain active substances from which much of our traditional pharmacopoeia has been obtained and can result in poisoning or act as endocrine disruptors if taken in excessive amounts or time periods.
Climbing plant. The female inflorescences or flower tips are used.It contains phloroglucinols, estrogenic, quercetin, kaempferol, tannins, phenolic acids essential oil and flavonoids. One of its components, 8-prenylnaringenin (8-PN) is the most powerful phytoestrogen known. Properties that are attributed: hypnotic, sedative, orexigenic.It is used as a flavoring and stabilizer of the beer.Indications German Commission E Ministry of Health, EMA and ESCOP: insomnia, nervousness, anxiety There is no scientific evidence showing an improvement in milk production.A possible estrogenic effect may be a decrease in milk production.The best galactogogue is a frequent and on-demand breastfeeding along with proper technique. During breastfeeding its consumption should be moderate or occasional.
A polymer made out of silicon-oxygen-methyl combination with a high molecular weight, water repellent and low superficial tension. It is used in many ways (dimethicone, simethicone, -see specific items)orally to treat infant colic and flatulence; as pediculicide, in cosmetic creams and lotions and skin protectants as to prevent ulcers and scars; arthroplasties, retinal detachments and reconstruction or cosmetic surgery as injections and implants. Silicone is widely distributed in our environment with several cosmetic and medicinal uses. No evidence of toxicity on human tissues has been shown. A 1994 report on immunological side effects in infants breastfed by mothers with silicone implants, was denied categorically by means of meta-analysis and other work. The absorption by oral or dermal route is negligible. Both a high molecular weight and polymer molecular structure make it practically impossible excretion in the milk and hence a significant amount of intestinal absorption by the infant. Those circumstances make silicone implants safe for lactation even if broken or manufacturing fault (Poly Implant Prothèse, PIP). After extensive analysis of such silicone prosthesis, where lack of health risk was demonstrated, it can be concluded that many of the initial recommendations published lacked scientific validity, including that carriers of such prosthesis should not breastfeed. Silicon levels in blood and milk of women with implants (55 ng / ml) are similar to those of women without implants (51 ng / ml), 13 times lower than that found in cow's milk (709 ng / ml) and 80 times lower than in commercial infant formulas (4403 ng / ml). American Academy of Pediatrics: Product usually compatible with breastfeeding. To view other possible effects on breastfeeding of breast implant unrelated to silicone, see the term 'Augmentation Mammoplasty'. See below the information of these related products:
CAS Number: 84696-11-7; 90028-20
Echinacea species (Echinacea angustifolia, Echinacea purpurea, Echinacea pallida) contain high molecular weight polysaccharides (e.g., heteroxylan, arabinogalactan) and lower molecular weight compounds (e.g., alkylamides, caffeoyl conjugates such as cichoric acid and echinacosides), but no single chemical is known to be responsible for echinacea's biological activity. Some products have been standardized based on echinacoside, and others on cichoric acid. Echinacea has no specific uses during breastfeeding, but is commonly used orally to treat or prevent upper respiratory infections. It is also used topically to treat skin infections. Excretion of some of the purportedly active alkamides was found in breastmilk in one mother. No data exist on the safety and efficacy of echinacea in nursing mothers or infants. In general, echinacea is well tolerated with gastrointestinal upset, diarrhea and constipation, skin rash and rarely allergic reactions reported. It may also alter the metabolism of some dugs metabolized by the P450 enzyme system. Some sources indicate that echinacea is safe in recommended doses, while others recommend avoiding it during breastfeeding because of the lack of published safety data. Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information #about dietary supplements# is available elsewhere on the LactMed Web site.
CAS Number: 84603-60-1
Goldenseal (Hydrastis canadensis) root contains berberine and other isoquinoline alkaloids. Goldenseal has traditionally been used as an anti-infective both systemically and topically, although high-quality studies of its efficacy and safety are lacking. It has also been used to mask illicit drugs in the urine, although it appears to be ineffective with modern laboratory methods. Goldenseal has been used topically by nursing mothers to treat sore nipples. No data exist on the excretion of any components of goldenseal into breastmilk or on the safety and efficacy of goldenseal in nursing mothers. Berberine can displace bilirubin from serum albumin, causing concern about exposure of newborn infants, because bilirubin can build up in the infant's brain, causing brain damage. However, the extent of berberine's passage from the mother to the infant is unknown. Most sources recommend avoiding exposure of neonates to goldenseal via breastfeeding or otherwise. Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information #about dietary supplements# is available elsewhere on the LactMed Web site.
CAS Number: 68990-15-8
Fenugreek (Trigonella foenum-graecum) seeds contain mucilage, trigonelline, 4-hydroxyisoleucine, sotolon, diosgenin, luteolin, phenolic acids, and protodioscin. Fenugreek has been used in a number of geographical regions worldwide as a galactogogue to increase milk supply and is included in numerous proprietary mixtures promoted to increase milk supply. The galactogogue effect of fenugreek may be primarily psychological. Evidence for a galactogogue effect is mostly anecdotal. A limited number of published studies of low to moderate quality have found mixed results for a galactogogue effect for fenugreek. A meta-analysis of controlled studies found fenugreek to have a mild galactogogue effect and unknown safety profile. Some evidence indicates that fenugreek might be more effective in early lactation than after 2 weeks postpartum. Some of these studies used a multi-ingredient combination products in which fenugreek was only one component, so the results might be different from studies in which fenugreek was used alone. Galactogogues should never replace evaluation and counseling on modifiable factors that affect milk production. Fenugreek is "generally recognized as safe" (GRAS) as a flavoring by the U.S. Food and Drug Administration. Limited scientific data exist on the safety of fenugreek in nursing mothers or infants, although it has a long history of use as a food and medicine in India and China. When used as a medicinal, it is generally well tolerated in adults, but gastrointestinal side effects such as nausea, vomiting, diarrhea and flatulence may occur. Liver toxicity has been reported, both taken alone and in herbal combinations that included fenugreek. Diarrhea and hepatomegaly occurred in a woman taking fennel, fenugreek, and goat's rue as galactagogues. Another mother reported increased heart rate and breast congestion. Allergic reactions, exacerbation of asthma, and a 14% decrease in serum potassium have been reported. One nursing mother developed toxic epidermal necrolysis thought to be cause by her intake of fenugreek as a galactagogue. Cross-reactions with chickpeas, peanuts, and other legumes are possible. Dosages typically used to increase milk supply are 1 to 6 grams daily; in dosages of about 25 grams or more daily, fenugreek may cause lowering of cholesterol and blood sugar. It can also interact with warfarin to cause bleeding. Caution should be used in giving high dosages to women with diabetes mellitus or those taking warfarin. In a survey of nursing mothers in the United States, 85 had used fenugreek as a galactogogue and 45% reported having experienced an adverse reaction from the supplement. Perhaps its most unusual side effect is the imparting an odor of maple syrup to the urine, sweat, feces, and possibly breastmilk by the sotolon in fenugreek. Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information #about dietary supplements# is available elsewhere on the LactMed Web site.
Hemlock is a very poisonous plant. In fact, all parts of the plant are toxic. Hemlock is most poisonous during the early stages of growth in the spring, but it is dangerous at all stages of growth. The poisons in hemlock are so deadly that people have died after eating animals that had eaten hemlock parts.
Despite serious safety concerns, hemlock is used for bronchitis, whooping cough, asthma, arthritis, and other conditions, but there is no good scientific evidence to support these uses. Due to extreme dilution it could be safe in homeopathic medicine however not much study has been done hence shall be avoided.
Due to high dilution of ingredients in homeopathic medicines they do not create much problem for baby. Mammaryplex | Apotheca Company is a homeopathic medicine and if your baby does not have any abnormal symptoms then there is nothing to worry about. Be careful with too much usage of ethanol based homeopathic medicines during breastfeeding.
Homeopathic medicines are usually safe in breastfeeding and if Mammaryplex | Apotheca Company has been recommended by doctor then there should be no concern about its usage in breastfeeding.
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week